Bitao Liang
CEO & CSO, Cytolynx Therapeutics
Bitao Liang is an Immunologist with a remarkable 26 years of experience in research and development, focusing on cellular immunology.
With 13 years dedicated to the Cell Therapy Industry, Bitao is a seasoned drug developer specializing in adaptive T cell therapy.
As a subject matter expert, Bitao possesses a profound knowledge of science and drug development, having extensive experience in research/discovery and CMC development.
Bitao has excelled as a functional leader, overseeing multiple product development programs from initial IND stages to the final BLA/MAA submissions.
In the role of CMC project leader, Bitao successfully managed a cross-functional team working on a CAR T program in collaboration with external partners, ensuring the establishment of global clinical supply.
With a strong managerial background, Bitao has effectively led various CMO programs and external collaborations for enhanced project outcomes.
Furthermore, Bitao has actively contributed to product and technology assessments for acquisition purposes, showcasing a versatile skill set.
Driven by a passion for developing talent, Bitao is dedicated to nurturing the professional and personal growth of young scientists and junior staff members.
A prolific inventor, Bitao has played a key role as the primary inventor or co-inventor in patents, patent applications, and provisional patent applications related to CAR T, CTL, and placental-derived mesenchymal stromal cells.
Bitao Liang pursued higher education at the East China University of Science and Technology and obtained a Ph.D. in Immunology from New York Medical College.
Bitao has held various significant positions in renowned organizations including Celgene and Bristol Myers Squibb, where roles ranged from Senior Director to Group Leader, contributing significantly to the field of immunology and drug development.
With a diverse and extensive professional background, Bitao Liang exemplifies expertise in cellular immunology, drug development, CMC project management, team leadership, and talent development.
Bitao's contributions to the industry are marked by innovation, leadership, and a commitment to advancing science and pharmaceutical development.
People also Viewed
Mutual Connections
People also Viewed
Mutual Connections
Bitao Liang
CEO & CSO, Cytolynx Therapeutics
Bitao Liang is an Immunologist with a remarkable 26 years of experience in research and development, focusing on cellular immunology.
With 13 years dedicated to the Cell Therapy Industry, Bitao is a seasoned drug developer specializing in adaptive T cell therapy.
As a subject matter expert, Bitao possesses a profound knowledge of science and drug development, having extensive experience in research/discovery and CMC development.
Bitao has excelled as a functional leader, overseeing multiple product development programs from initial IND stages to the final BLA/MAA submissions.
In the role of CMC project leader, Bitao successfully managed a cross-functional team working on a CAR T program in collaboration with external partners, ensuring the establishment of global clinical supply.
With a strong managerial background, Bitao has effectively led various CMO programs and external collaborations for enhanced project outcomes.
Furthermore, Bitao has actively contributed to product and technology assessments for acquisition purposes, showcasing a versatile skill set.
Driven by a passion for developing talent, Bitao is dedicated to nurturing the professional and personal growth of young scientists and junior staff members.
A prolific inventor, Bitao has played a key role as the primary inventor or co-inventor in patents, patent applications, and provisional patent applications related to CAR T, CTL, and placental-derived mesenchymal stromal cells.
Bitao Liang pursued higher education at the East China University of Science and Technology and obtained a Ph.D. in Immunology from New York Medical College.
Bitao has held various significant positions in renowned organizations including Celgene and Bristol Myers Squibb, where roles ranged from Senior Director to Group Leader, contributing significantly to the field of immunology and drug development.
With a diverse and extensive professional background, Bitao Liang exemplifies expertise in cellular immunology, drug development, CMC project management, team leadership, and talent development.
Bitao's contributions to the industry are marked by innovation, leadership, and a commitment to advancing science and pharmaceutical development.
People also Viewed